The drinks contain a mix of protein and vitamins that will help GLP-1 users reduce weight in a healthy manner.

Veru's pivot with enobosarm: groundbreaking Phase 2b results enhance GLP-1 therapy outcomes. A positive launch could yield ...

As of 2021–2022, approximately 74% of U.S. adults aged 20 and older were classified as overweight or obese, with 42.1% ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...

Dozens of Ozempic, Mounjaro and Wegovy users are reporting drug-induced hepatitis, prompting medical experts to call for ...

Researchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to the need for ongoing management of patients on GLP-1s, an obesity expert ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

The BOOST® Nutritional Drink brand unveiled today its new BOOST® Advanced Nutritional Shake designed to support nutritional ...

KANSAS CITY, MISSOURI, US — Already on the path toward healthier, nutrient-dense products, the increasing popularity of GLP-1 ...

“GLP-1 agonists represent a major breakthrough in ... “They have been linked to reducing inflammation and supporting metabolic function, and this makes them more than just weight-loss aids ...